Complement activation and its prognostic role in post-cardiac arrest patients

Area of Science:

• Cardiology
• Immunology
• Critical Care Medicine

Background:

• Cardiac arrest leads to widespread ischemia and hypoxia, followed by reperfusion injury.
• Predicting outcomes for comatose patients post-cardiac arrest is clinically challenging.
• The role of complement activation in post-cardiac arrest prognosis is not fully understood.

Purpose of the Study:

• To investigate the hypothesis that complement activation extent predicts mortality in comatose cardiac arrest patients.
• To evaluate the C3a/C3 ratio as a prognostic marker for 30-day survival.

Main Methods:

• Prospective cohort study of 46 comatose cardiac arrest patients.
• Therapeutic hypothermia (32-34°C for 24h) followed by rewarming.
• Measurement of complement products (C3a, C3, C4d, C4, SC5b9, Bb) via ELISA at multiple time points.
• 30-day mortality follow-up.

Main Results:

• Complement activation, indicated by a higher C3a/C3 ratio, was observed in non-survivors compared to survivors at all measured time points.
• The C3a/C3 ratio at 24 hours post-hypothermia initiation was a significant independent predictor of 30-day mortality.
• This predictive value remained significant even when accounting for age, sex, and APACHE II score.

Conclusions:

• Complement activation is a significant pathophysiological process in post-cardiac arrest patients.
• The extent of complement activation, specifically the C3a/C3 ratio, correlates with 30-day survival.
• The C3a/C3 ratio shows potential as a valuable tool for estimating prognosis in comatose post-cardiac arrest patients.